WALDENSTROM'S MACROGLOBULINEMIA (WM)

Clinical trials for WALDENSTROM'S MACROGLOBULINEMIA (WM) explained in plain language.

Never miss a new study

Get alerted when new WALDENSTROM'S MACROGLOBULINEMIA (WM) trials appear

Sign up with your email to follow new studies for WALDENSTROM'S MACROGLOBULINEMIA (WM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill takes on hard-to-treat blood cancers in early trial

Disease control Recruiting now

This early-stage study tests an experimental drug called EXS73565 in about 50 adults with certain blood cancers (like lymphoma or leukemia) that returned or didn't respond to standard treatments. The main goal is to check safety and find the right dose, while also seeing if the d…

Matched conditions: WALDENSTROM'S MACROGLOBULINEMIA (WM)

Phase: PHASE1 • Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

WALDENSTROM'S MACROGLOBULINEMIA (WM)

Get alerted when new WALDENSTROM'S MACROGLOBULINEMIA (WM) trials appear

New pill takes on hard-to-treat blood cancers in early trial